Lars H. Vorland

1.9k total citations
43 papers, 1.6k citations indexed

About

Lars H. Vorland is a scholar working on Microbiology, Epidemiology and Molecular Biology. According to data from OpenAlex, Lars H. Vorland has authored 43 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Microbiology, 15 papers in Epidemiology and 12 papers in Molecular Biology. Recurrent topics in Lars H. Vorland's work include Antimicrobial Peptides and Activities (12 papers), Infant Nutrition and Health (11 papers) and Urinary Tract Infections Management (7 papers). Lars H. Vorland is often cited by papers focused on Antimicrobial Peptides and Activities (12 papers), Infant Nutrition and Health (11 papers) and Urinary Tract Infections Management (7 papers). Lars H. Vorland collaborates with scholars based in Norway, United States and Czechia. Lars H. Vorland's co-authors include Hanne H. Haukland, Hilde Ulvatne, Ørjan Samuelsen, Øystein Rekdal, Tore Jarl Gutteberg, John S. Svendsen, Terje Traavik, Jeanette H. Andersen, Lars Kåre Dotterud and Baldur Sveinbjørnsson and has published in prestigious journals such as The Lancet, FEBS Letters and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Lars H. Vorland

41 papers receiving 1.5k citations

Peers

Countries citing papers authored by Lars H. Vorland

Since Specialization

Citations

This map shows the geographic impact of Lars H. Vorland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars H. Vorland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars H. Vorland more than expected).

Fields of papers citing papers by Lars H. Vorland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars H. Vorland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars H. Vorland. The network helps show where Lars H. Vorland may publish in the future.

Co-authorship network of co-authors of Lars H. Vorland

This figure shows the co-authorship network connecting the top 25 collaborators of Lars H. Vorland. A scholar is included among the top collaborators of Lars H. Vorland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars H. Vorland. Lars H. Vorland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The effect of UVB radiation on skin microbiota in patients with atopic dermatitis and healthy controls 2008 ·International Journal of Circumpolar Health ·Lars Kåre Dotterud, Tom Wilsgaard, Lars H. Vorland, Edvard S. Falk	49
2	No detectable Chlamydia pneumoniae and cytomegalovirus DNA in leukocytes in subjects with echolucent and echogenic carotid artery plaques 2006 ·International Journal of Cardiology ·Dag S. Halvorsen, (unknown), (unknown), Ellisiv B. Mathiesen, Inger Njølstad, Tore Jarl Gutteberg, Lars H. Vorland, John‐Bjarne Hansen	7
3	Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus 2005 ·FEBS Letters ·Ørjan Samuelsen, Hanne H. Haukland, Håvard Jenssen, Manuela Krämer, (unknown), Hilde Ulvatne, Lars H. Vorland	32
4	Lactoferricin B inhibits bacterial macromolecular synthesis in and 2004 ·FEMS Microbiology Letters ·Hilde Ulvatne, Ørjan Samuelsen, Hanne H. Haukland, Mordechai R. Kramer, Lars H. Vorland	109
5	Chlamydia pneumoniae IgA‐ and IgG antibodies in young survivors of myocardial infarction. A comparison of antibody detection by a microimmunofluorescence test and an enzyme immunoassay 2002 ·Journal of Internal Medicine ·Dag S. Halvorsen, (unknown), Inger Njølstad, Tore Jarl Gutteberg, Lars H. Vorland, (unknown)	12
6	LABORATORY DIAGNOSIS OF RESPIRATORY DISEASES: PCR VERSUS SEROLOGY 2001 ·Nucleosides Nucleotides & Nucleic Acids ·H. Haaheim, Lars H. Vorland, Tore Jarl Gutteberg	9
7	The prevalence of antibiotic resistance in bacterial respiratory pathogens from Norway is low 2001 ·Clinical Microbiology and Infection ·Bjørn‐Erik Kristiansen, (unknown), (unknown), Yngvar Tveten, Lars H. Vorland	12
8	The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm 2001 ·FEBS Letters ·Hanne H. Haukland, Hilde Ulvatne, (unknown), Lars H. Vorland	112
9	Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts 2001 ·Antiviral Research ·Jeanette H. Andersen, (unknown), Lars H. Vorland, Terje Traavik, Tore Jarl Gutteberg	151
10	Retningslinjer for diagnostikk og behandling av sår hals 2000 ·Tidsskrift for Den Norske Laegeforening ·Signe Flottorp, Andrew D Oxman, John G. Cooper, Per Hjortdahl, Sverre Sandberg, Lars H. Vorland	4
11	Retningslinjer for diagnostikk og behandling av akutte vannlatingsplager hos kvinner 2000 ·Tidsskrift for Den Norske Laegeforening ·Signe Flottorp, Andrew D Oxman, John G. Cooper, Per Hjortdahl, Sverre Sandberg, Lars H. Vorland	2
12	Lactoferrin: A multifunctional glycoprotein 1999 ·Apmis ·Lars H. Vorland	217
13	Mould Allergy in Schoolchildren in Relation to Airborne Fungi and Residential Characteristics in Homes and Schools in Northern Norway 1996 ·Indoor Air ·Lars Kåre Dotterud, Lars H. Vorland, Edvard S. Falk	14
14	Viable fungi in indoor air in homes and schools in the Sør‐Varanger community during winter 1995 ·Pediatric Allergy and Immunology ·Lars Kåre Dotterud, Lars H. Vorland, E S Falk	31
15	Pneumonia – a Clinical or Radiographic Diagnosis? 1992 ·Scandinavian Journal of Infectious Diseases ·Hasse Melbye, B. P. Berdal, Bjørn Straume, Harold Russell, Lars H. Vorland, W. Lanier Thacker	48
16	Early response in septicemia in newborns and their mothers. Effect of Escherichia coli, Streptococcus agalactiae and tumor necrosis factor on lactoferrin release and the generation of tissue thromboplastin. 1991 ·PubMed ·Tore Jarl Gutteberg, Knut Dalaker, (unknown), Lars H. Vorland	1
17	Early response in neonatal septicemia. The effect of Escherichia coli, Streptococcus agalactiae and tumor necrosis factor on the generation of lactoferrin 1990 ·Apmis ·Tore Jarl Gutteberg, Knut Dalaker, Lars H. Vorland	9
18	[Serology in lower respiratory tract infections. Virus, mycoplasma and ornithosis serology]. 1988 ·PubMed ·Arnfinn Sundsfjord, Lars H. Vorland, Hasse Melbye	1
19	EVALUATION OF TWO VACUUM BOTTLE BLOOD CULTURE MEDIA – SUPPLEMENTED PEPTONE BROTH AND BRAIN HEART INFUSION BROTH 1987 ·Acta Pathologica Microbiologica Scandinavica Series B Microbiology ·Per Sandven, E. Arne Høiby, Lars H. Vorland	1
20	WHAT MAKES BACTERIA PATHOGENIC ? 1972 ·The Lancet ·Lars H. Vorland	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact